RELATING TO FOOD AND DRUGS -- RHODE ISLAND FOOD, DRUGS, AND, COSMETICS ACT
H7192 amends Rhode Island’s Food, Drugs, and Cosmetics Act to add a new prohibited act for cosmetics. Under the bill, it would be unlawful to manufacture, sell, deliver, hold for sale, or offer for sale any cosmetic whose label does not contain a complete and accurate listing of every component ingredient in the product. The measure is framed as a labeling and consumer-information requirement, aimed at ensuring cosmetic products are fully disclosed to buyers.
The bill does not change the broader structure of the state’s food and drug enforcement laws, but it expands the list of prohibited acts in § 21-31-3 to include incomplete cosmetic ingredient labeling. If enacted, it would give the Department of Health an additional basis to treat noncompliant cosmetics as unlawful under the Rhode Island Food, Drugs, and Cosmetics Act, affecting manufacturers, distributors, retailers, and other sellers of cosmetics in the state. The act would take effect immediately upon passage.
This bill would amend § 21-31-3 of the Rhode Island General Laws to make incomplete or inaccurate cosmetic ingredient labeling a prohibited act under the state’s Food, Drugs, and Cosmetics Act. The practical effect is to require cosmetics sold in Rhode Island to carry a complete ingredient list, and to expose noncompliant products to enforcement action under existing food and drug regulatory authority. It would primarily affect cosmetic manufacturers, importers, wholesalers, retailers, and any other entities that manufacture, hold, or offer cosmetics for sale in the state.
No committee transcript or recorded vote information was provided, so there is no documented debate or roll-call history to assess. Based on the bill text and caption, the measure appears consumer-protection oriented and straightforward, with an emphasis on transparency in cosmetic labeling. The available materials do not show any expressed opposition or support from legislators, stakeholders, or the public.
The bill’s main policy issue is whether Rhode Island should require a complete and accurate ingredient disclosure for all cosmetics sold in the state. Potential points of contention could include compliance costs for manufacturers and retailers, especially smaller businesses, and whether the state requirement aligns with or goes beyond federal cosmetic labeling standards. No specific objections or supporters are identified in the provided record, so any contention is only inferential from the regulatory burden the bill could impose.